P.14.15 EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY

Autor:	V.D. Corleto, Cristiano Pagnini, G. Delle Fave, F. Desideri, F. Menasci, Marina Capasso
Rok vydání:	2016
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Gastroenterology medicine.disease Infliximab Internal medicine medicine Adalimumab Center (algebra and category theory) business Life study medicine.drug
Zdroj:	Digestive and Liver Disease. 48:e199-e200
ISSN:	1590-8658
DOI:	10.1016/s1590-8658(16)30320-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c015b49e551dd95649a1d79a7acf61f9 https://doi.org/10.1016/s1590-8658(16)30320-6 Zobrazit plný text záznamu Full Text from ScienceDirect